Haemonetics Corporation (HAE)
Largest Insider Buys in Sector
HAE Stock Price History Chart
HAE Stock Performance
About Haemonetics Corporation
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system. It also provides automated blood component and manual whole blood collection systems, such as MCS brand apheresis equipment to collect specific blood components from the donor; disposable whole blood collection and component storage sets; SafeTrace Tx blood bank information system; and BloodTrack blood management software, a suite of blood management and bedside transfusion solutions that combines software with hardware components, as well as an extension of the hospital's blood bank information system. In addition, the company offers hospital products comprising TEG, ClotPro, and HAS hemostasis analyzer systems that provide a comprehensive assessment of a patient's overall hemostasis; TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions; and Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries. It markets and sells its products through direct sales force, independent distributors, and sales representatives. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts.
Insider Activity of Haemonetics Corporation
Over the last 12 months, insiders at Haemonetics Corporation have bought $0 and sold $3.46M worth of Haemonetics Corporation stock.
On average, over the past 5 years, insiders at Haemonetics Corporation have bought $323,720 and sold $6M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 4,000 shares for transaction amount of $323,720 was made by ABERNATHY ROBERT E (director) on 2020‑08‑11.
List of Insider Buy and Sell Transactions, Haemonetics Corporation
| 2024-07-26 | Sale | President, Global Hospital | 4,312 0.0085% | $91.15 | $393,039 | -15.79% | ||
| 2024-07-12 | Sale | EVP, Chief Technology Officer | 79 0.0002% | $90.00 | $7,110 | 0.00% | ||
| 2024-07-11 | Sale | EVP, Chief Technology Officer | 2,136 0.0045% | $90.00 | $192,240 | 0.00% | ||
| 2024-05-29 | Sale | EVP and General Counsel | 12,990 0.0257% | $88.08 | $1.14M | -6.56% | ||
| 2024-05-29 | Sale | President, Global Hospital | 8,857 0.0174% | $87.53 | $775,253 | -6.56% | ||
| 2024-05-20 | Sale | EVP and General Counsel | 1,604 0.0032% | $95.08 | $152,508 | -12.75% | ||
| 2024-05-20 | Sale | EVP, Global Manufacturing | 987 0.0019% | $95.08 | $93,844 | -12.75% | ||
| 2024-05-20 | Sale | President, Global Hospital | 686 0.0013% | $95.11 | $65,245 | -12.75% | ||
| 2024-05-17 | Sale | EVP and General Counsel | 1,073 0.0021% | $95.00 | $101,935 | -12.96% | ||
| 2024-05-17 | Sale | EVP, Global Manufacturing | 822 0.0016% | $94.82 | $77,942 | -12.96% | ||
| 2024-05-16 | Sale | EVP and General Counsel | 985 0.002% | $96.14 | $94,698 | -12.11% | ||
| 2024-05-16 | Sale | EVP, Global Manufacturing | 770 0.0015% | $96.14 | $74,028 | -12.11% | ||
| 2024-05-16 | Sale | President, Global Hospital | 733 0.0015% | $96.04 | $70,397 | -12.11% | ||
| 2024-05-06 | Sale | EVP, Chief Technology Officer | 2,305 0.0045% | $95.00 | $218,975 | -11.96% | ||
| 2023-09-12 | Sale | President, Global Hospital | 228 0.0005% | $90.65 | $20,668 | -5.52% | ||
| 2023-09-11 | Sale | EVP, Chief Technology Officer | 2,305 0.0045% | $90.00 | $207,450 | -6.34% | ||
| 2023-09-05 | Sale | director | 10,215 0.0202% | $87.68 | $895,651 | -2.33% | ||
| 2023-07-18 | Sale | EVP, Global Manufacturing | 4,928 0.0095% | $90.00 | $443,520 | -6.13% | ||
| 2023-06-07 | Sale | President, Global Hospital | 2,538 0.005% | $88.04 | $223,446 | -2.38% | ||
| 2023-05-30 | Sale | EVP, Chief Technology Officer | 2,304 0.0045% | $83.33 | $191,992 | +2.78% |
Insider Historical Profitability
| Basil Michelle L | EVP and General Counsel | 31257 0.0622% | $81.62 | 0 | 31 | |
| Lingamneni Anila | EVP, Chief Technology Officer | 21331 0.0425% | $81.62 | 0 | 9 | |
| Llorens Josep | EVP, Global Manufacturing | 21310 0.0424% | $81.62 | 0 | 14 | |
| Strong Stewart W | President, Global Hospital | 18196 0.0362% | $81.62 | 0 | 9 | |
| Simon, Christopher | President & CEO | 213724 0.4255% | $81.62 | 1 | 21 | +13.41% |
| CONCANNON BRIAN | President & CEO | 147040 0.2928% | $81.62 | 8 | 57 | +8.69% |
| GELBMAN RONALD G | director | 48384 0.0963% | $81.62 | 1 | 16 | +4.67% |
| LINDOP CHRISTOPHER J | CFO & EVP Business Development | 45350 0.0903% | $81.62 | 12 | 15 | +4.66% |
| ALLEN PETER M | President, Global Plasma | 34102 0.0679% | $81.62 | 20 | 22 | +7.23% |
| MEELIA RICHARD J | director | 32050 0.0638% | $81.62 | 0 | 4 | |
| White Jonathan | Chief Science and Technology | 30507 0.0607% | $81.62 | 7 | 5 | +3.73% |
| Burke William P. Mr. | EVP, Chief Financial Officer | 30291 0.0603% | $81.62 | 0 | 26 | |
| FOOTE SUSAN BARTLETT | director | 20740 0.0413% | $81.62 | 1 | 9 | <0.0001% |
| HANLON SUSAN M | VP Finance | 20464 0.0407% | $81.62 | 18 | 20 | +5.11% |
| Jesse Sandra | EVP and Chief Legal Officer | 20096 0.04% | $81.62 | 3 | 2 | +5.46% |
| MERRIMAN RONALD | director | 17807 0.0355% | $81.62 | 1 | 9 | <0.0001% |
| FORISH JOSEPH J | VP, Human Resources | 17279 0.0344% | $81.62 | 9 | 10 | +4.98% |
| Davies Kent J | Chief Operating Officer | 16891 0.0336% | $81.62 | 0 | 2 | |
| KROLL MARK W | 16231 0.0323% | $81.62 | 0 | 10 | ||
| Burns Brian R | EVP, Global QA/RA | 16235 0.0323% | $81.62 | 0 | 1 | |
| EBBELING ROBERT B | Vice President, Operations | 15849 0.0316% | $81.62 | 9 | 4 | +6.35% |
| GRANADILLO PEDRO P | director | 15335 0.0305% | $81.62 | 4 | 13 | +2.48% |
| Ryding Neil Mr. | EVP, Global Manufacturing | 15226 0.0303% | $81.62 | 0 | 4 | |
| Miller Laurie A. | SVP, Human Resources | 12697 0.0253% | $81.62 | 0 | 6 | |
| Granville William | VP, Manufacturing | 12188 0.0243% | $81.62 | 1 | 0 | +4.75% |
| ABERNATHY ROBERT E | director | 12048 0.024% | $81.62 | 1 | 0 | +18.77% |
| Selman Byron | President, Global Markets | 12010 0.0239% | $81.62 | 0 | 2 | |
| LOPEZ ALICIA R | VP, Corporate Affairs | 11017 0.0219% | $81.62 | 13 | 24 | +4.9% |
| Kelly Michael P | President, Global Markets | 10987 0.0219% | $81.62 | 0 | 11 | |
| BEST LAWRENCE C | director | 10001 0.0199% | $81.62 | 1 | 7 | +0.57% |
| NUTTER BRAD | Chairman of the Board | 9387 0.0187% | $81.62 | 1 | 11 | +26.67% |
| Nighan Warren JR | VP WW Q&R Affairs | 7908 0.0157% | $81.62 | 0 | 2 | |
| Helsel Dave | EVP, Global Manufacturing | 6856 0.0137% | $81.62 | 2 | 0 | +2.96% |
| McDaniel Kathleen | EVP Global Human Resources | 5013 0.01% | $81.62 | 0 | 1 | |
| Popovsky Mark A | VP, Corporate Medical Director | 4891 0.0097% | $81.62 | 7 | 5 | +4.13% |
| Goldstein Dan | VP, Corporate Controller | 4447 0.0089% | $81.62 | 0 | 40 | |
| Gordon Mikael | President, Global Markets | 4442 0.0088% | $81.62 | 3 | 5 | +6.2% |
| Scanlan Jacqueline | SVP, Global Human Resources | 4216 0.0084% | $81.62 | 0 | 24 | |
| Still William Roche | VP & Gen Mrg, Therapeutics Bus | 4193 0.0083% | $81.62 | 6 | 2 | +1.45% |
| O'Shaughnessy James | 3781 0.0075% | $81.62 | 1 | 0 | +4.75% | |
| Brancazio Phillip John | VP, Global Manufacturing | 3052 0.0061% | $81.62 | 3 | 0 | +0.64% |
| SWENSON STEPHEN | VP & General Mgr, Global Plasm | 3024 0.006% | $81.62 | 1 | 2 | +4.75% |
| Pare Anthony | 2523 0.005% | $81.62 | 1 | 2 | +4.75% | |
| SAKURADA YUTAKA | President, Japan & Asia | 2347 0.0047% | $81.62 | 2 | 0 | +16.87% |
| Dockendorff Charles J | director | 2226 0.0044% | $81.62 | 0 | 2 | |
| RYAN RONALD J | VP and CFO | 2101 0.0042% | $81.62 | 5 | 4 | +5.1% |
| BEUCLER MARK | 1989 0.004% | $81.62 | 1 | 0 | +4.75% | |
| Bolorforosh Said | EVP, Chief Technology Officer | 1977 0.0039% | $81.62 | 0 | 3 | |
| WILLIAMSON DONNA C E | director | 1300 0.0026% | $81.62 | 0 | 4 | |
| Conneely Jan | VP & GM, Arryx, Inc. | 1041 0.0021% | $81.62 | 1 | 0 | +4.75% |
| ECKERT ULRICH | President, Europe & Latin Am | 890 0.0018% | $81.62 | 2 | 4 | +2.88% |
| Corlin Remi | President, Asia | 884 0.0018% | $81.62 | 0 | 2 | |
| Hattori Keiko | President, Haemonetics Japan | 716 0.0014% | $81.62 | 1 | 0 | +4.75% |
| RUXIN MICHAEL I | VP Global Software Strategies | 215 0.0004% | $81.62 | 1 | 0 | +6.76% |
| Sakai Ryoji | President, Japan | 0 0% | $81.62 | 0 | 3 | |
| Lawlor Thomas | President, Patient Division | 0 0% | $81.62 | 0 | 1 |
Institutional Investor Ownership
| Capital Research Global Investors | $569.69M | 13.13 | 6.67M | +2.32% | +$12.9M | 0.13 | |
| BlackRock | $510.77M | 11.77 | 5.98M | -0.92% | -$4.75M | 0.01 | |
| The Vanguard Group | $460.66M | 10.62 | 5.4M | -0.17% | -$766,357.65 | 0.01 | |
| Wellington Management Company | $364.52M | 8.4 | 4.27M | +30.68% | +$85.59M | 0.06 | |
| Neuberger Berman | $323.28M | 7.45 | 3.79M | +7.28% | +$21.93M | 0.27 | |
| State Street | $156.38M | 3.6 | 1.83M | +2.38% | +$3.63M | 0.01 | |
| Franklin Templeton Investments | $118.95M | 2.74 | 1.39M | -17.73% | -$25.63M | 0.04 | |
| ROYCE & ASSOCIATES INC | $108.11M | 2.49 | 1.27M | +31.07% | +$25.63M | 0.96 | |
| T Rowe Price Investment Management Inc | $103.97M | 2.4 | 1.22M | +11.53% | +$10.75M | 0.06 | |
| Geode Capital Management | $96.07M | 2.21 | 1.13M | +3.72% | +$3.44M | 0.01 | |
| Dimensional Fund Advisors | $78.61M | 1.81 | 921,070 | +11.41% | +$8.05M | 0.02 | |
| Boston Trust Walden Corp | $60.76M | 1.4 | 711,865 | -0.64% | -$392,695.34 | 0.44 | |
| Westfield Capital Management Co Lp | $59.73M | 1.38 | 699,861 | -1.71% | -$1.04M | 0.31 | |
| Fisher Asset Management Llc | $59.58M | 1.37 | 698,040 | -1.92% | -$1.16M | 0.03 | |
| Schroder Investment Management Group | $53.6M | 1.24 | 628,019 | -4.38% | -$2.46M | 0.06 | |
| Northern Trust | $49.11M | 1.13 | 575,410 | -8.45% | -$4.53M | 0.01 | |
| T. Rowe Price | $48.01M | 1.11 | 562,454 | +38.61% | +$13.37M | 0.01 | |
| Charles Schwab | $46.67M | 1.08 | 546,785 | +2.26% | +$1.03M | 0.01 | |
| Allspring Global Investments | $42.93M | 0.99 | 502,993 | +132.76% | +$24.49M | 0.07 | |
| BNY Mellon | $41.58M | 0.96 | 487,226 | -5.69% | -$2.51M | 0.01 | |
| Silvercrest Asset Management Group Inc | $38.71M | 0.89 | 453,494 | New | +$38.71M | 0.27 | |
| Boston Partners | $38.3M | 0.87 | 444,180 | -37.21% | -$22.7M | 0.05 | |
| Royal Bank of Canada | $34.63M | 0.8 | 405,797 | +125.16% | +$19.25M | 0.01 | |
| Millennium Management LLC | $27.82M | 0.64 | 325,998 | +125.28% | +$15.47M | 0.02 | |
| Aristotle Capital Boston LLC | $27.44M | 0.63 | 321,526 | +5.32% | +$1.39M | 0.83 | |
| Morgan Stanley | $26.7M | 0.62 | 312,878 | -28.87% | -$10.84M | <0.01 | |
| Bank of America | $24.59M | 0.57 | 288,092 | +78.76% | +$10.83M | <0.01 | |
| Ameriprise Financial | $23.26M | 0.54 | 272,500 | -5.07% | -$1.24M | 0.01 | |
| HERITAGE ASSET MANAGEMENT INC | $22.19M | 0.52 | 261,673 | -3.98% | -$920,225.84 | 0.11 | |
| CalPERS | $20.32M | 0.47 | 238,101 | +3.65% | +$715,574.39 | 0.01 | |
| Heartland Advisors Inc | $18.7M | 0.43 | 219,065 | -1.19% | -$224,641.20 | 0.12 | |
| Fidelity Investments | $16.76M | 0.39 | 196,329 | -87.58% | -$118.16M | <0.01 | |
| JPMorgan Chase | $16.52M | 0.38 | 193,565 | +9.77% | +$1.47M | <0.01 | |
| Victory Capital Management Inc | $16.23M | 0.37 | 190,127 | -8.3% | -$1.47M | 0.02 | |
| Nuveen | $15.35M | 0.35 | 179,867 | +0.03% | +$5,206.35 | <0.01 | |
| London Co Of Virginia | $15.29M | 0.35 | 179,091 | +13.7% | +$1.84M | 0.08 | |
| Fort Washington Investment Advisors Inc Oh | $15.26M | 0.35 | 178,761 | New | +$15.26M | 0.1 | |
| Retirement Systems of Alabama | $15.29M | 0.35 | 179,175 | +0.13% | +$19,118.40 | 0.06 | |
| Prudential Financial | $15.13M | 0.35 | 177,294 | +2.89% | +$424,872.30 | 0.02 | |
| Great Lakes Advisors® | $14.3M | 0.33 | 167,550 | -1.01% | -$145,521.74 | 0.13 | |
| Arrowstreet Capital, Limited Partnership | $14.3M | 0.33 | 167,497 | +6% | +$809,125.42 | 0.01 | |
| Goldman Sachs | $13.75M | 0.32 | 161,146 | -15.74% | -$2.57M | <0.01 | |
| RhumbLine Advisers | $13.73M | 0.32 | 160,819 | +0.46% | +$63,244.21 | 0.01 | |
| Schwartz Investment Counsel Inc | $12.89M | 0.3 | 151,000 | +26.89% | +$2.73M | 0.47 | |
| Oberweis Asset Management Inc | $12.26M | 0.28 | 143,695 | +35.72% | +$3.23M | 0.89 | |
| PEREGRINE CAPITAL MANAGEMENT INC | $11.49M | 0.27 | 134,603 | +22.02% | +$2.07M | 0.33 | |
| Deutsche Bank | $11.26M | 0.26 | 131,925 | -35.38% | -$6.17M | 0.01 | |
| Emerald Advisers, Inc. | $11.13M | 0.26 | 130,437 | -11.46% | -$1.44M | 0.45 | |
| AQR Capital | $10.87M | 0.25 | 128,775 | -7.3% | -$855,866.38 | 0.02 | |
| SEI Investments Company | $10.54M | 0.24 | 123,487 | -3.09% | -$336,186.75 | 0.02 |